SCHOFIELD, Wis., June 3, 2014 /PRNewswire/ -- PuraMed BioScience®,
Inc., (PMBS: OTCBB), a researcher, developer, and marketer of
over-the-counter (OTC) medicinal and healthcare products, announced
today that Patricia McMurtrie will
hold the positions of COO, President, and Director, effective
May 27, 2014. In this role, Ms.
McMurtrie will be responsible for the oversight of day-to-day
business functions as well as key product development and
distribution functions.
"I'm pleased to welcome Patricia to the PuraMed team," said
Russ Mitchell Chairman and Chief
Executive Officer of PuraMed BioScience. "Patricia has an intimate
knowledge of the company and our products. I believe that her
presence will support and drive PuraMed's continued growth and
prosperity as we move forward."
"I am excited to be part of the PuraMed BioScience team," said
McMurtrie. "I've seen LipiGesic® M, a natural migraine pain
reliever, make a difference in the lives of people in my personal
circle. It is extremely rewarding to be a part of a company that
can change people's lives for the better. I look forward to the
development and distribution of additional products that are just
as effective in the lives of others."
Ms. McMurtrie brings over twenty years of varied business
experience relative to the marketing and communications field. As
co-owner and marketing director for Envision Marketing &
Design, LLC, since 2001, Patricia has extensive experience working
with many clients from a variety of industries. This knowledge will
be valuable as she plays a key role in the development of future
strategic plans.
About PuraMed BioScience, Inc.
PuraMed BioScience engages in the research, development, and
marketing of non-prescription medicinal and healthcare products. In
addition to LipiGesic M, PuraMed BioScience plans to launch
additional cannabinoid enhanced anti-inflammatory and anxiolytic
products as it moves forward in the development of its CBD product
line.
Forward-Looking Statements
This news release contains forward-looking statements regarding
PuraMed BioScience, Inc., and its future business plans, which
statements involve known and unknown risks and uncertainties. Such
risks and uncertainties may cause actual results and future
achievements of PuraMed BioScience to be materially different from
those implied by these forward-looking statements. PuraMed
BioScience has and undertakes no obligation to provide public
updates and revisions to these forward-looking statements to
reflect any changes in its expectations of future events.
Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and
CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com
SOURCE PuraMed BioScience, Inc.